Related Experiment Video
Updated: Apr 9, 2026

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.5K
The Aging Brain Care Medical Home: Preliminary Data
Michael A LaMantia1,2,3, Catherine A Alder4, Christopher M Callahan1,2,3
1Center for Aging Research, Indiana University, Indianapolis, Indiana.
Journal of the American Geriatrics Society
|June 23, 2015
Summary
The Aging Brain Care program improved health for older adults with dementia and depression. This collaborative care model shows promise for managing the health of our aging population.
Area of Science:
- Gerontology
- Public Health
- Health Services Research
Background:
- Dementia and depression significantly impact older adults' health and healthcare costs.
- Existing care models often struggle to address the complex needs of this population.
- Population health management programs are needed to improve outcomes for Medicare beneficiaries.
Purpose of the Study:
- To evaluate the effectiveness of the Aging Brain Care (ABC) Medical Home program.
- To assess improvements in care, health outcomes, and medical costs for older adults with dementia or depression.
- To determine the impact of a collaborative care intervention on depressive symptoms and caregiver stress.
Main Methods:
- The ABC Medical Home program expanded a collaborative dementia and depression care model.
- The program served 1,650 older adults in a safety-net hospital system.
- 20 clinical staff were hired and trained to deliver collaborative care interventions over 18 months.
Main Results:
- 66% of participants with high depression scores showed at least a 50% reduction in depressive symptoms.
- 51% of caregivers for individuals with dementia reported at least a 50% reduction in stress.
- The program demonstrated progress in improving the health of older adults with dementia and depression.
Conclusions:
- The ABC Medical Home program shows initial promise for improving care for older adults with dementia and depression.
- Scalable and practical models are crucial for addressing the challenges of an aging population.
- Collaborative care interventions can effectively reduce depressive symptoms and caregiver stress.
Related Concept Videos
Documentation in Long-Term and Home Healthcare Setting
1.7K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.7K
Aging
1.0K
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
1.0K
Specialized Care Centers and Settings-II
1.3K
Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Specialized Care Centers and Settings-I
1.5K
Specialized care settings or centers are situated in convenient locations within the community and offer care to a specific group or population. They consist of daycare facilities, mental health facilities, rural health facilities, educational institutions, industries, shelters for the homeless, and rehabilitation facilities.
Daycare centers
They provide several functions. Some facilities care for healthy newborns and children whose parents work, while others are medically focused and care for...
Daycare centers
They provide several functions. Some facilities care for healthy newborns and children whose parents work, while others are medically focused and care for...
1.5K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K

